002390 信邦制药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)2.2641.4954.2053.3424.730
总资产报酬率 ROA (%)1.7291.1103.0172.3102.829
投入资产回报率 ROIC (%)2.0011.2883.4972.6723.239

边际利润分析
销售毛利率 (%)17.44217.17319.01619.16520.898
营业利润率 (%)5.5184.2255.9594.9816.977
息税前利润/营业总收入 (%)5.5403.3506.5595.5497.854
净利润/营业总收入 (%)4.7062.5815.4764.2245.778

收益指标分析
经营活动净收益/利润总额(%)106.506172.391108.803106.719111.147
价值变动净收益/利润总额(%)0.1181.5782.37311.9420.931
营业外收支净额/利润总额(%)-4.517-37.3832.775-0.935-7.215

偿债能力分析
流动比率 (X)3.5752.9072.6292.1612.024
速动比率 (X)2.9022.3202.1431.7771.685
资产负债率 (%)18.83222.24622.74627.86129.081
带息债务/全部投入资本 (%)8.65313.32313.26919.18019.869
股东权益/带息债务 (%)1,049.025646.603649.425418.799400.538
股东权益/负债合计 (%)417.123334.097325.857249.518236.408
利息保障倍数 (X)21.28012.17315.2699.0405.831

营运能力分析
应收账款周转天数 (天)157.441161.420161.257164.537147.586
存货周转天数 (天)76.22374.25769.95669.02662.554